Literature DB >> 23515236

Primary liver transplantation vs liver resection followed by transplantation for transplantable hepatocellular carcinoma: Liver functional quality and tumor characteristics matter.

Mehmet Fatih Can1, Christopher B Hughes.   

Abstract

Liver resection (LR) and primary liver transplantation (LT) are two potentially curative treatment modalities for patients with hepatocellular carcinoma (HCC). If an underlying chronic liver disease exists, however, making a decision on which method should be selected is difficult. If a patient has no chronic liver disease, LR may be the preferable option with salvage transplantation (ST) in mind in case of recurrence. Presence of a moderate-to-severe liver failure accompanying HCC usually warrants primary LT. The treatment of patients with HCC and early-stage chronic liver disease remains controversial. The advantages of "LR-followed-by-ST-if-needed" strategy include less complicated index operation, no need for immunosuppression, use of donor livers for other patients in today's organ shortage setting and comparable survival rates. However, primary LT has its own advantages as it also treats underlying chronic liver disease with carcinogenic potential, removes undetected tumor nodules and potentially eliminates need for a ST. An article recently published by Fuks et al in Hepatology offers an approach by which selecting between LR-followed-by-ST and immediate LT might be easier. Here we discuss the results of the aforementioned report in the light of currently available knowledge.

Entities:  

Keywords:  Chronic liver disease; Hepatocellular carcinoma; Liver resection; Liver transplantation; Salvage transplantation; Survival

Year:  2013        PMID: 23515236      PMCID: PMC3600564          DOI: 10.4240/wjgs.v5.i1.5

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  16 in total

1.  Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.

Authors:  David Fuks; Safi Dokmak; Valérie Paradis; Momar Diouf; François Durand; Jacques Belghiti
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

2.  Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary?

Authors:  R Takamori; L L Wong; C Dang; L Wong
Journal:  Liver Transpl       Date:  2000-01       Impact factor: 5.799

3.  Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.

Authors:  Carlos Margarit; Alfredo Escartín; Lluis Castells; Víctor Vargas; Elena Allende; Itxarone Bilbao
Journal:  Liver Transpl       Date:  2005-10       Impact factor: 5.799

4.  Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.

Authors:  Thomas Decaens; Françoise Roudot-Thoraval; Solange Hadni-Bresson; Carole Meyer; Jean Gugenheim; Francois Durand; Pierre-Henri Bernard; Olivier Boillot; Laurent Sulpice; Yvon Calmus; Jean Hardwigsen; Christian Ducerf; Georges-Philippe Pageaux; Sebastien Dharancy; Olivier Chazouilleres; Daniel Cherqui; Christophe Duvoux
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

Review 5.  Characteristics of common solid liver lesions and recommendations for diagnostic workup.

Authors:  Nimer Assy; Gattas Nasser; Agness Djibre; Zaza Beniashvili; Saad Elias; Jamal Zidan
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

6.  Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Authors:  John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

7.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Authors:  Sean F Altekruse; Katherine A McGlynn; Marsha E Reichman
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

8.  Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma.

Authors:  Umberto Cillo; Alessandro Vitale; Marco Bassanello; Patrizia Boccagni; Alberto Brolese; Giacomo Zanus; Patrizia Burra; Stefano Fagiuoli; Fabio Farinati; Massimo Rugge; Davide Francesco D'Amico
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

9.  Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?

Authors:  René Adam; Daniel Azoulay; Denis Castaing; Rony Eshkenazy; Gérard Pascal; Kentaro Hashizume; Didier Samuel; Henri Bismuth
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

10.  An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution.

Authors:  Shimul A Shah; Sean P Cleary; Jensen C C Tan; Alice C Wei; Steve Gallinger; David R Grant; Paul D Greig
Journal:  Ann Surg Oncol       Date:  2007-05-24       Impact factor: 5.344

View more
  5 in total

Review 1.  Hepatectomy for hepatocellular carcinoma in the era of liver transplantation.

Authors:  Wen-Ping Lu; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

2.  Predicting recurrence patterns after resection of hepatocellular cancer.

Authors:  Ser Yee Lee; Ioannis T Konstantinidis; Anne A Eaton; Mithat Gönen; T Peter Kingham; Michael I D'Angelica; Peter J Allen; Yuman Fong; Ronald P DeMatteo; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2014-07-16       Impact factor: 3.647

3.  The role of liver transplantation or resection for patients with early hepatocellular carcinoma.

Authors:  Kuan-Chun Hsueh; Ting-Ying Lee; Chew-Teng Kor; Tsung-Ming Chen; Tzu-Ming Chang; Shun-Fa Yang; Chung-Bao Hsieh
Journal:  Tumour Biol       Date:  2015-10-22

4.  Impact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCC.

Authors:  Zhenhua Hu; Qijun Zhang; Jie Zhou; Zhiwei Li; Jie Xiang; Lin Zhou; Jian Wu; Min Zhang; Shusen Zheng
Journal:  BMJ Open       Date:  2015-09-09       Impact factor: 2.692

5.  Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival.

Authors:  Jinsoo Rhu; Jong Man Kim; Gyu Seong Choi; Choon Hyuck David Kwon; Jae-Won Joh
Journal:  Ann Surg Treat Res       Date:  2018-08-31       Impact factor: 1.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.